Zobrazeno 1 - 10
of 23
pro vyhledávání: '"JESSICA JACOB"'
Publikováno v:
Systemic Practice and Action Research.
Autor:
MOIZ JAVED, MUHAMMAD Z ARIF, ABDUL RAHMAN HALAWA, JESSICA JACOB, ANTHONY J VACCARELLO, LUIS MEZA, ALI I SAEED, ROSS M BREMNER
Publikováno v:
Chest. 162:A347-A348
Autor:
Seanna Davidson, Daniel Chamberlain, Jessica Jacob, Liza Hopkins, Maria Gomez, Sonia Wutzke, Therese Riley
Publikováno v:
Systemic Practice and Action Research
The turn to complexity in public health over the past 20 years has come as practitioners, policy makers and scholars lament the lack of progress in addressing wicked problems such as obesity, chronic disease and the social determinants of health. Sys
Autor:
Kathleen Tor, Jessica Jacob, Miguel Gonzalez Valez, Majd Freijat, Osama Qasim Agha, Suhaireirene Suady Barake, Ashwini Arjuna
Publikováno v:
Critical Care Medicine. 51:172-172
Autor:
Jessica Jacob, Andrew Talon, Melinda Wang, Tina Younger, Andres Borja Alvarez, Dipika Sharma, LeNae Pohl, Ashwini Arjuna
Publikováno v:
Critical Care Medicine. 51:459-459
Publikováno v:
Chest. 162:A2557
Autor:
MUHAMMAD Z ARIF, MOIZ JAVED, ABDUL RAHMAN HALAWA, JESSICA JACOB, LUIS MEZA, ANTHONY J VACCARELLO, ALI I SAEED
Publikováno v:
Chest. 162:A2073
Autor:
Jessica Jacobs
Publikováno v:
Akademisk Kvarter, Iss 27 (2024)
In this article I will argue that the online filmmaking and screening initiative Film Geographies is shaping (and has been shaped by) our understanding of what a geographical film is. It has achieved this by opening up a previously unavailable space
Externí odkaz:
https://doaj.org/article/d1c37afd70434529bf5a212dca7d3ff1
Publikováno v:
Can J Public Health
People who inject drugs (PWID) are disproportionately impacted by hepatitis C virus (HCV). Despite the availability and efficacy of direct-acting antiviral (DAA) HCV therapies, treatment rates remain low among PWID. Among PWID, those who are young (u
Publikováno v:
Can J Public Health
People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) and have low rates of direct-acting antiviral (DAA) treatment uptake, despite universal coverage of the medication in most Canadian settings. Investigation into